Literature DB >> 3405665

Metoclopramide-induced methemoglobinemia.

G L Kearns1, D H Fiser.   

Abstract

The case of a 3-week-old male infant is described. After receiving an iatrogenic overdose of metoclopramide (1.0 mg/kg every six hours) throughout a 36-hour period for the treatment of suspected gastroesophageal reflux, he became cyanotic, lethargic, and irritable, he fed poorly, and he had diarrhea and respiratory distress. Methemoglobinemia (20.5%) and reduced oxyhemoglobin saturation (79%) were identified. The patient had an excellent clinical response following a single IV dose of methylene blue. Subsequently, methemoglobin reductase activity was normal and there was no measurable hemoglobin M. The diagnosis of methemoglobinemia should be considered in any infant receiving large doses of metoclopramide who has clinical findings of cyanosis, ashen color, or a history of lethargy and/or motor restlessness.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3405665

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Methaemoglobinaemia produced by metoclopramide in an adult.

Authors:  S C Grant; J R Close; C L Bray
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

2.  Methaemoglobin production in normal adults inhaling low concentrations of nitric oxide.

Authors:  J D Young; O Dyar; L Xiong; S Howell
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

Review 3.  Drug-induced methaemoglobinaemia. Treatment issues.

Authors:  M D Coleman; N A Coleman
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

4.  Methylene blue unresponsive methemoglobinemia.

Authors:  Seyed Mostafa Mirakbari
Journal:  Indian J Crit Care Med       Date:  2014-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.